Sino Biological partners AI antibody development prediction platform for CRO
Sino Biological has partnered with California’s Ainnocence to add the company’s AI-based prediction technology to its antibody development CRO services.
Ainnocence said its platform provides fast, efficient and accurate prediction of antibody-antigen interaction, including binding affinity assessment. The third-generation AI system delivers virtual screening and multi-objective pharmacological profile optimization for small molecule, antibody and other complex therapies.
Sino Bio is a global reagent supplier that also offers CRO services. Terms of the agreement were not disclosed.
The Ainnocence platform has a computational screening capacity of up to 10^10 protein sequences or chemical compounds that is available within hours. The company said its technology provides a short list of candidates with improved wet lab hit rate, and a reduced discovery time and cost.
Rob Burgess, Sino Biological’s Chief Business Officer, said “The addition of Ainnocence’s AI-based antibody-antigen binding prediction technology will enable Sino Biological to further enhance its antibody development CRO services offering, thus saving customers precious development time and ensuring antibody-antigen binding affinities that meet their strict demands. We look forward to working with the Ainnocence team to offer next-generation antibody design and development services.”
“I’m confident that our partnership with Sino Biological will catalyze Ainnocence’s Biologics AI design applications in the biotech industry, and ultimately accelerate clinical translation of cutting-edge medical technologies.” stated Lurong Pan, Ainnocence CEO.
Sino Biological focuses on recombinant protein production and antibody development. Its products, which are independently developed and produced, include recombinant proteins, antibodies and cDNA clones. It also offers pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.
This article was first published in ChinaBioToday on March 24
Image: Stock Photo Secrets